litlas
ログインアカウント作成

Pauline Brice

1992–2025 年に発表

109
論文数
20,173
被引用数
78
h 指数
106
i10 指数

被引用数

Pauline Brice の年別被引用数1989 年: 被引用 1 件1994 年: 被引用 3 件1995 年: 被引用 3 件1996 年: 被引用 5 件1997 年: 被引用 12 件1998 年: 被引用 21 件1999 年: 被引用 21 件2000 年: 被引用 33 件2001 年: 被引用 23 件2002 年: 被引用 38 件2003 年: 被引用 38 件2004 年: 被引用 35 件2005 年: 被引用 56 件2006 年: 被引用 62 件2007 年: 被引用 78 件2008 年: 被引用 89 件2009 年: 被引用 78 件2010 年: 被引用 75 件2011 年: 被引用 110 件2012 年: 被引用 92 件2013 年: 被引用 103 件2014 年: 被引用 122 件2015 年: 被引用 117 件2016 年: 被引用 89 件2017 年: 被引用 167 件2018 年: 被引用 161 件2019 年: 被引用 507 件2020 年: 被引用 619 件2021 年: 被引用 527 件2022 年: 被引用 390 件2023 年: 被引用 235 件2024 年: 被引用 429 件2025 年: 被引用 162 件1990〜1993 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 1,344 件、この内訳の 22.5%フランス: 引用元論文 528 件、この内訳の 8.8%イタリア: 引用元論文 456 件、この内訳の 7.6%ドイツ: 引用元論文 405 件、この内訳の 6.8%イギリス: 引用元論文 380 件、この内訳の 6.4%中国: 引用元論文 311 件、この内訳の 5.2%カナダ: 引用元論文 228 件、この内訳の 3.8%スペイン: 引用元論文 212 件、この内訳の 3.6%スイス: 引用元論文 196 件、この内訳の 3.3%オランダ: 引用元論文 195 件、この内訳の 3.3%オーストラリア: 引用元論文 190 件、この内訳の 3.2%日本: 引用元論文 156 件、この内訳の 2.6%
0%22.5%その他 22.9%

機関

分野

  • Medicine91.1%
  • Immunology and Microbiology4%
  • Biochemistry, Genetics and Molecular Biology3.7%
  • Computer Science0.3%
  • Physics and Astronomy0.2%
  • Engineering0.1%
  • その他0.6%

トピック

  • Lymphoma Diagnosis and Treatment21.1%
  • CAR-T cell therapy research6.2%
  • CNS Lymphoma Diagnosis and Treatment6.1%
  • Viral-associated cancers and disorders5.5%
  • Chronic Lymphocytic Leukemia Research4.5%
  • Cancer Immunotherapy and Biomarkers4.5%
  • その他52.1%

共著者

全論文

検索で開く
  1. Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial

    著者: Steven M. Horwitz, Owen A. O’Connor, Barbara Pro, Tim Illidge, Michelle A. Fanale, Ranjana H. Advani, Nancy L. Bartlett, Jacob Haaber Christensen, Franck Morschhauser, Eva Domingo‐Doménech, Giuseppe Rossi, Won Seog Kim, Tatyana Feldman, Anne Lennard, David Belada, Árpád Illés, Kensei Tobinai, Kunihiro Tsukasaki, Su‐Peng Yeh, Andrei R. Shustov, Andreas Hüttmann, Kerry J. Savage, Sam Yuen, Swaminathan P. Iyer, Pier Luigi Zinzani, Zhaowei Hua, Meredith Little, Shangbang Rao, Joseph Woolery, Thomas Manley, Lorenz Trümper, David M. Aboulafia, Ranjana H. Advani, Önder Alpdoğan, Kiyoshi Ando, Luca Arcaini, Luca Baldini, Naresh Bellam, Nancy L. Bartlett, David Belada, Dina Ben Yehuda, Fabio Benedetti, Peter Borchman, Dominique Bordessoule, Pauline Brice, Javier Briones, Dolores Caballero, Angelo Michele Carella, Hung Chang, June Weon Cheong, Seok‐Goo Cho, Ilseung Choi, Sylvain Choquet, Andrei Coliţă, Angela Giovanna Congui, Francesco d’Amore, Nam H. Dang, Kelly Davison, Sophie de Guibert, Peter de Nully Brown, Vincent Delwail, Judit Demeter, Francesco Di Raimondo, Young Rok, Eva Domingo, Michael G. Douvas, Martin Dreyling, Thomas Ernst, Michelle A. Fanale, Keith Fay, Tatyana Feldman, Silvia Ferrero, Ian W. Flinn, Andres Forero‐Torres, Christopher P. Fox, Jonathan W. Friedberg, Noriko Fukuhara, José A. García‐Marco, Jorge Gayoso Cruz, José Codina, Rémy Gressin, Andrew Grigg, Ronit Gurion, Jacob Haaber Christensen, Corinne Haïoun, Roman Hájek, Mathias Hänel, Kiyohiko Hatake, Robert Hensen, Netanel A. Horowitz, Steven M. Horwitz, Andreas Hüttmann, Árpád Illés, Tim Illidge, Kenichi Ishizawa, Miguel Islas‐Ohlmayer, Eric D. Jacobsen, Murali Janakiram, Wojciech Jurczak, Mark Kaminski ほか 69 名 - The Lancet 2018 被引用: 726

  2. Phase II Study of the Efficacy and Safety of Pembrolizumab for Relapsed/Refractory Classic Hodgkin Lymphoma

    著者: Robert Chen, Pier Luigi Zinzani, Michelle A. Fanale, Philippe Armand, Nathalie A. Johnson, Pauline Brice, John Radford, Vincent Ribrag, Daniel Molin, Theodoros P. Vassilakopoulos, Akihiro Tomita, Bastian von Tresckow, Margaret A. Shipp, Yinghua Zhang, Alejandro D. Ricart, Arun Balakumaran, Craig H. Moskowitz, for the KEYNOTE-087 - Journal of Clinical Oncology 2017 被引用: 985

  3. Rituximab plus Lenalidomide in Advanced Untreated Follicular Lymphoma

    著者: Franck Morschhauser, Nathan Fowler, Pierre Feugier, Réda Bouabdallah, Hervé Tilly, M. Lia Palomba, Christophe Fruchart, Edward N. Libby, Olivier Casasnovas, Ian W. Flinn, Corinne Haïoun, Hervé Maisonneuve, Loïc Ysebaert, Nancy L. Bartlett, Kamal Bouabdallah, Pauline Brice, Vincent Ribrag, Nicolas Daguindau, Steven Le Gouill, Gian M. Pica, Alejandro Martı́n, Armando López‐Guillermo, Jean-François Larouche, Kiyoshi Ando, María Gomes da Silva, Marc André, Pierre Zachée, Laurie H. Sehn, Kensei Tobinai, Guillaume Cartron, David Liu, Jianming Wang, Luc Xerri, Gilles Salles - New England Journal of Medicine 2018 被引用: 362

  4. Sustained Progression-Free Survival Benefit of Rituximab Maintenance in Patients With Follicular Lymphoma: Long-Term Results of the PRIMA Study

    著者: Emmanuel Bachy, John F. Seymour, Pierre Feugier, Fritz Offner, Armando López‐Guillermo, David Belada, Luc Xerri, John Catalano, Pauline Brice, François Lemonnier, Alejandro Martı́n, Olivier Casasnovas, Lars Møller Pedersen, Véronique Dorvaux, David Simpson, Sirpa Leppä, Jean Gabarre, María Gomes da Silva, Sylvie Glaisner, Loïc Ysebaert, Anne Vekhoff, Tanin Intragumtornchai, Steven Le Gouill, Andrew Lister, Jane Estell, Giuseppe Milone, Anne Sonet, Jonathan Farhi, Harald Zeuner, Hervé Tilly, Gilles Salles - Journal of Clinical Oncology 2019 被引用: 278

  5. Classical Hodgkin lymphoma

    著者: Pauline Brice, Eric de Kerviler, Jonathan W Friedberg - The Lancet 2021 被引用: 162

  6. Brentuximab Vedotin (SGN-35) in Patients With Relapsed or Refractory Systemic Anaplastic Large-Cell Lymphoma: Results of a Phase II Study

    著者: Barbara Pro, Ranjana H. Advani, Pauline Brice, Nancy L. Bartlett, Joseph D. Rosenblatt, Tim Illidge, Jeffrey Matous, Radhakrishnan Ramchandren, Michelle A. Fanale, Joseph M. Connors, Yin Yang, Eric L. Sievers, Dana A. Kennedy, Andrei R. Shustov - Journal of Clinical Oncology 2012 被引用: 990

  7. Comparison in low-tumor-burden follicular lymphomas between an initial no-treatment policy, prednimustine, or interferon alfa: a randomized study from the Groupe d'Etude des Lymphomes Folliculaires. Groupe d'Etude des Lymphomes de l'Adulte.

    著者: Pauline Brice, Y Bastion, Éric Lepage, Nicole Brousse, Corinne Haïoun, Philippe Moreau, Nicole Straetmans, Hervé Tilly, I Tabah, Philippe Solal‐Céligny - Journal of Clinical Oncology 1997 被引用: 641

  8. Five-year follow-up of KEYNOTE-087: pembrolizumab monotherapy for relapsed/refractory classical Hodgkin lymphoma

    著者: Philippe Armand, Pier Luigi Zinzani, Hun Ju Lee, Nathalie A. Johnson, Pauline Brice, John Radford, Vincent Ribrag, Daniel Molin, Theodoros P. Vassilakopoulos, Akihiro Tomita, Bastian von Tresckow, Margaret A. Shipp, Alex F. Herrera, Jianxin Lin, Eunhee Kim, Samhita Chakraborty, Patricia Marinello, Craig H. Moskowitz - Blood 2023 被引用: 105

  9. Pembrolizumab in relapsed or refractory Hodgkin lymphoma: 2-year follow-up of KEYNOTE-087

    著者: Robert Chen, Pier Luigi Zinzani, Hun Ju Lee, Philippe Armand, Nathalie A. Johnson, Pauline Brice, John Radford, Vincent Ribrag, Daniel Molin, Theodoros P. Vassilakopoulos, Akihiro Tomita, Bastian von Tresckow, Margaret A. Shipp, Jianxin Lin, Eunhee Kim, Akash Nahar, Arun Balakumaran, Craig H. Moskowitz - Blood 2019 被引用: 329

  10. Early Positron Emission Tomography Response–Adapted Treatment in Stage I and II Hodgkin Lymphoma: Final Results of the Randomized EORTC/LYSA/FIL H10 Trial

    著者: Marc André, T. Girinsky, Massimo Federico, Oumédaly Reman, Catherine Fortpied, Manuel Gotti, Olivier Casasnovas, Pauline Brice, Richard van der Maazen, Alessandro Re, Véronique Edeline, Christophe Fermé, Gustaaf van Imhoff, Francesco Merli, Réda Bouabdallah, Catherine Sebban, Lena Specht, Aspasia Stamatoullas, Richard Delarue, Valeria Fiaccadori, Monica Bellei, Tiana Raveloarivahy, Annibale Versari, Martin Hutchings, Michel Meignan, John Raemaekers - Journal of Clinical Oncology 2017 被引用: 532

  11. Nivolumab Combined With Brentuximab Vedotin for Relapsed/Refractory Primary Mediastinal Large B-Cell Lymphoma: Efficacy and Safety From the Phase II CheckMate 436 Study

    著者: Pier Luigi Zinzani, Armando Santoro, Giuseppe Gritti, Pauline Brice, Paul M. Barr, John Kuruvilla, David Cunningham, Justin Kline, Nathalie A. Johnson, Neha Mehta–Shah, Thomas Manley, Stephen Francis, Manish Sharma, Alison J. Moskowitz - Journal of Clinical Oncology 2019 被引用: 181

  12. Six-Year Results From RELEVANCE: Lenalidomide Plus Rituximab (R2) Versus Rituximab-Chemotherapy Followed by Rituximab Maintenance in Untreated Advanced Follicular Lymphoma

    著者: Franck Morschhauser, Loretta J. Nastoupil, Pierre Feugier, Jean‐Marc Schiano de Colella, Hervé Tilly, Maria Lia Palomba, Emmanuel Bachy, Christophe Fruchart, Edward N. Libby, Olivier Casasnovas, Ian W. Flinn, Corinne Haïoun, Hervé Maisonneuve, Loïc Ysebaert, Nancy L. Bartlett, Kamal Bouabdallah, Pauline Brice, Vincent Ribrag, Steven Le Gouill, Nicolas Daguindau, Stéphanie Guidez, Gian Matteo Pica, Alejandro Martı́n, Armondo López-Guillermo, Jean-François Larouche, Kiyoshi Ando, María Gomes da Silva, Marc André, Wu Kalung, Laurie H. Sehn, Koji Izutsu, Guillaume Cartron, Argyrios Gkasiamis, Russell Crowe, Luc Xerri, Nathan Fowler, Gilles Salles - Journal of Clinical Oncology 2022 被引用: 68

  13. A gene-expression profiling score for prediction of outcome in patients with follicular lymphoma: a retrospective training and validation analysis in three international cohorts

    著者: Sarah Huet, Bruno Tesson, Jean‐Philippe Jais, Andrew L. Feldman, Laura Magnano, Emilie Thomas, Alexandra Traverse‐Glehen, Benoît Albaud, Marjorie Carrère, Luc Xerri, Stephen M. Ansell, Lucile Baseggio, Cécile Réyès, Karin Tarte, Sandrine Boyault, Corinne Haïoun, Brian K. Link, Pierre Feugier, Armando López‐Guillermo, Hervé Tilly, Pauline Brice, Sandrine Hayette, Fabrice Jardin, Fritz Offner, Pierre Sujobert, David Gentien, Alain Viari, Elı́as Campo, James R. Cerhan, Gilles Salles - The Lancet Oncology 2018 被引用: 220

  14. Rituximab maintenance for 2 years in patients with high tumour burden follicular lymphoma responding to rituximab plus chemotherapy (PRIMA): a phase 3, randomised controlled trial

    著者: Gilles Salles, John F. Seymour, Fritz Offner, Armando López‐Guillermo, David Belada, Luc Xerri, Pierre Feugier, Réda Bouabdallah, John Catalano, Pauline Brice, Dolores Caballero, Corinne Haïoun, Lars Møller Pedersen, Alain Delmer, David Simpson, Sirpa Leppä, Pierre Soubeyran, Anton Hagenbeek, Olivier Casasnovas, Tanin Intragumtornchai, Christophe Fermé, María Gomes da Silva, Catherine Sebban, Andrew Lister, Jane Estell, Giuseppe Milone, Anne Sonet, Myriam Mendila, Bertrand Coiffier, Hervé Tilly - The Lancet 2010 被引用: 1,066

  15. Impact of cancer chemotherapy before ovarian cortex cryopreservation on ovarian tissue transplantation

    著者: Catherine Poirot, Anne Fortin, Jean‐Marc Lacorte, Jean-Paul Akakpo, Catherine Genestie, Jean Paul Vernant, Pauline Brice, Philippe Morice, Thierry Leblanc, Jean Gabarre, Alain Delmer, Yasmina Badachi, Véronique Drouineaud, Sébastien Gouy, Céline Chalas, Sophie Egels, Nathalie Dhédin, Philippe Touraine, Marc Dommergues, Géraldine Lebègue, Jean‐Philippe Wolf, F. Capron, Gilles Lefèbvre, Nicolas Boissel, for the CAROLéLISA Cooperative Group - Human Reproduction 2019 被引用: 90

  16. Five-year results of brentuximab vedotin in patients with relapsed or refractory systemic anaplastic large cell lymphoma

    著者: Barbara Pro, Ranjana H. Advani, Pauline Brice, Nancy L. Bartlett, Joseph D. Rosenblatt, Tim Illidge, Jeffrey Matous, Radhakrishnan Ramchandren, Michelle A. Fanale, Joseph M. Connors, Keenan Fenton, Dirk Huebner, Juan Pinelli, Dana A. Kennedy, Andrei R. Shustov - Blood 2017 被引用: 241

  17. Prognostic value of baseline metabolic tumor volume in early-stage Hodgkin lymphoma in the standard arm of the H10 trial

    著者: Anne‐Ségolène Cottereau, Annibale Versari, Annika Loft, Olivier Casasnovas, Monica Bellei, Romain Ricci, Stéphane Bardet, Antonio Castagnoli, Pauline Brice, John Raemaekers, Bénédicte Deau, Catherine Fortpied, Tiana Raveloarivahy, Emelie Van Zele, Loïc Chartier, Thierry Vander Borght, Massimo Federico, Martin Hutchings, Umberto Ricardi, Marc André, Michel Meignan - Blood 2018 被引用: 189

  18. Risk Factors and Outcomes for Patients With Follicular Lymphoma Who Had Histologic Transformation After Response to First-Line Immunochemotherapy in the PRIMA Trial

    著者: Clémentine Sarkozy, Marek Trněný, Luc Xerri, Nick Wickham, Pierre Feugier, Sirpa Leppä, Pauline Brice, Pierre Soubeyran, María Gomes da Silva, Christiane Mounier, Fritz Offner, Jehan Dupuis, Dolores Caballero, Danielle Canioni, Marlton Paula, Richard Delarue, Pierre Zachée, John Seymour, Gilles Salles, Hervé Tilly - Journal of Clinical Oncology 2016 被引用: 182

  19. Allogeneic transplantation in advanced cutaneous T-cell lymphomas (CUTALLO): a propensity score matched controlled prospective study

    著者: Adèle de Masson, M. Beylot‐Barry, C. Ram‐Wolff, Caroline Ram-Wolff, Stéphane Dalle, Stéphane Dalle, S. Oro, Saskia Ingen-Housz-Oro, Corentin Orvain, O. Dereure, Olivier Dereure, Amandine Charbonnier, Christine Longvert, Christine Longvert, Stéphane Barete, E. Wierzbicka-Hainaut, F. Aubin, Marie‐Thérèse Rubio, Marc Bernard, Marc Bernard, Roch Houot, Roch Houot, Anne Pham-Ledard, Pauline Brice, Pauline Brice, Hélène Labussière-Wallet, Florent Grange, Florent Grange, Katayoun Jondeau, Laurence Michel, Laurence Michel, Maxime Battistella, Etienne Daguindau, Michael Loschi, Michael Loschi, Nathalie Franck, Natacha Maillard, Anne Huynh, Anne Huynh, Stéphanie Nguyen, G. Chaby, Patrice Céballos, Yannick Le Corre, Yannick Le Corre, Jacques-Olivier Bay, Henri Adamski, Emmanuel Bachy, Edouard Forcade, Gérard Socié, Martine Bagot, Sylvie Chevret, Sylvie Chevret, Adèle de Masson, Régis Peffault de Latour, Caroline Ram-Wolff, Jean-Baptiste Mear, Marie Beylot-Barry, M. D’Incan, Jean-Baptiste Mear, Corentin Orvain, Michel d'Incan, O. Dereure, Corentin Orvain, Julie Abraham, Christine Longvert, Stéphane Barète, S. Boulinguez, E. Wierzbicka-Hainaut, François Aubin, Serge Boulinguez, Marc Bernard, Aline Schmidt-Tanguy, Roch Houot, Anne Pham‐Ledard, Aline Schmidt-Tanguy, Pauline Brice, Hélène Labussière‐Wallet, David Michonneau, Pauline Brice, Hélène Labussière-Wallet, Katayoun Jondeau, Laurence Michel, Hélène Moins-Teisserenc, Maxime Battistella, Etienne Daguindau, Michael Loschi, Alexandra Picard, Nathalie Franck, Natacha Maillard, Anne Huynh, Nathalie Franck, Natacha Maillard, G. Chaby, Patrice Céballos, Y. Le Corre, Guillaume Chaby, Jacques-Olivier Bay, Yannick Le Corre, Emmanuel Bachy, Edouard Forcade ほか 57 名 - The Lancet 2023 被引用: 65

  20. No Evidence for the Benefit of Gonadotropin-Releasing Hormone Agonist in Preserving Ovarian Function and Fertility in Lymphoma Survivors Treated With Chemotherapy: Final Long-Term Report of a Prospective Randomized Trial

    著者: Isabelle Demeestere, Pauline Brice, Fedro A. Peccatori, Alain Kentos, Jehan Dupuis, Pierre Zachée, Olivier Casasnovas, Éric Van Den Neste, Julie Dechène, Viviane De Maertelaer, Dominique Bron, Yvon Englert - Journal of Clinical Oncology 2016 被引用: 238

  21. The Prognostic Impact of CD163-Positive Macrophages in Follicular Lymphoma: A Study from the BC Cancer Agency and the Lymphoma Study Association

    著者: Robert Kridel, Luc Xerri, Bénédicte Gelas‐Dore, King Tan, Pierre Feugier, Ayesha Y. Vawda, Danielle Canioni, Pedro Farinha, Sami Boussetta, Alden A. Moccia, Pauline Brice, Elizabeth A. Chavez, Alastair H. Kyle, David W. Scott, Ashley D. Sanders, Bettina Fabiani, Graham W. Slack, Andrew I. Minchinton, Corinne Haïoun, Joseph M. Connors, Laurie H. Sehn, Christian Steidl, Randy D. Gascoyne, Gilles Salles - Clinical Cancer Research 2015 被引用: 118

  22. Combining brentuximab vedotin with dexamethasone, high-dose cytarabine and cisplatin as salvage treatment in relapsed or refractory Hodgkin lymphoma: the phase II HOVON/LLPC Transplant BRaVE study

    著者: Marie José Kersten, Julia Driessen, Josée M. Zijlstra, Wouter J. Plattel, Franck Morschhauser, Pieternella J. Lugtenburg, Pauline Brice, Martin Hutchings, Thomas Gastinne, Roberto Liu, Coreline N. Burggraaff, Marcel Nijland, Sanne H. Tonino, Anne I.J. Arens, Roelf Valkema, Harm van Tinteren, Marta López‐Yurda, Arjan Diepstra, Daphne de Jong, Anton Hagenbeek - Haematologica 2020 被引用: 102

  23. Nivolumab combined with brentuximab vedotin for R/R primary mediastinal large B-cell lymphoma: a 3-year follow-up

    著者: Pier Luigi Zinzani, Armando Santoro, Giuseppe Gritti, Pauline Brice, Paul M. Barr, John Kuruvilla, David Cunningham, Justin Kline, Nathalie A. Johnson, Neha Mehta–Shah, Julie Lisano, Rachael Wen, Alev Akyol, Alison J. Moskowitz - Blood Advances 2023 被引用: 35

  24. PET-adapted treatment for newly diagnosed advanced Hodgkin lymphoma (AHL2011): a randomised, multicentre, non-inferiority, phase 3 study

    著者: Olivier Casasnovas, Réda Bouabdallah, Pauline Brice, Julien Lazarovici, Hervé Ghesquières, Aspasia Stamatoullas, Jehan Dupuis, Anne‐Claire Gac, Thomas Gastinne, Bertrand Joly, Krimo Bouabdallah, Emmanuelle Nicolas‐Virelizier, Pierre Feugier, Franck Morschhauser, Richard Delarue, H. Farhat, Philippe Quittet, Alina Berriolo-Riedinger, Adrian Tempescul, Véronique Edeline, Hervé Maisonneuve, Luc‐Matthieu Fornecker, Thierry Lamy, Alain Delmer, Peggy Dartigues, Laurent Martin, Marc André, Nicolas Mounier, Alexandra Traverse‐Glehen, Michel Meignan - The Lancet Oncology 2019 被引用: 209